Neoadjuvant use of ipilimumab in locally advanced melanoma.
Journal Article (Journal Article)
Recent advances in immune modulating therapies show great promise for patients with advanced melanoma, however optimal strategies for achieving long-term disease control in locally advanced melanoma are unclear. We present two cases of neoadjuvant ipilimumab, one case in combination with isolated limb infusion (ILI) followed by surgical resection and one followed by surgery alone. Both patients have had durable responses. These cases highlight the ongoing need for prospective trials in the neoadjuvant setting.
Full Text
Duke Authors
Cited Authors
- Howie, LJ; Tyler, DS; Salama, AKS
Published Date
- December 2015
Published In
Volume / Issue
- 112 / 8
Start / End Page
- 841 - 843
PubMed ID
- 26768512
Pubmed Central ID
- 26768512
Electronic International Standard Serial Number (EISSN)
- 1096-9098
Digital Object Identifier (DOI)
- 10.1002/jso.24079
Language
- eng
Conference Location
- United States